1. Home
  2. VSH vs MIRM Comparison

VSH vs MIRM Comparison

Compare VSH & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • MIRM
  • Stock Information
  • Founded
  • VSH 1962
  • MIRM 2018
  • Country
  • VSH United States
  • MIRM United States
  • Employees
  • VSH N/A
  • MIRM N/A
  • Industry
  • VSH Electrical Products
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSH Technology
  • MIRM Health Care
  • Exchange
  • VSH Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • VSH 2.3B
  • MIRM 2.5B
  • IPO Year
  • VSH N/A
  • MIRM 2019
  • Fundamental
  • Price
  • VSH $16.87
  • MIRM $51.12
  • Analyst Decision
  • VSH Hold
  • MIRM Strong Buy
  • Analyst Count
  • VSH 2
  • MIRM 9
  • Target Price
  • VSH $20.50
  • MIRM $66.22
  • AVG Volume (30 Days)
  • VSH 1.4M
  • MIRM 351.2K
  • Earning Date
  • VSH 08-06-2025
  • MIRM 08-11-2025
  • Dividend Yield
  • VSH 2.40%
  • MIRM N/A
  • EPS Growth
  • VSH N/A
  • MIRM N/A
  • EPS
  • VSH N/A
  • MIRM N/A
  • Revenue
  • VSH $2,906,544,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • VSH $4.10
  • MIRM $36.76
  • Revenue Next Year
  • VSH $6.15
  • MIRM $17.48
  • P/E Ratio
  • VSH N/A
  • MIRM N/A
  • Revenue Growth
  • VSH N/A
  • MIRM 69.31
  • 52 Week Low
  • VSH $10.35
  • MIRM $36.20
  • 52 Week High
  • VSH $24.69
  • MIRM $54.78
  • Technical
  • Relative Strength Index (RSI)
  • VSH 51.41
  • MIRM 50.28
  • Support Level
  • VSH $16.81
  • MIRM $50.92
  • Resistance Level
  • VSH $17.55
  • MIRM $52.63
  • Average True Range (ATR)
  • VSH 0.47
  • MIRM 1.49
  • MACD
  • VSH -0.13
  • MIRM -0.35
  • Stochastic Oscillator
  • VSH 16.30
  • MIRM 5.30

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: